High-grade Serous Ovarian Carcinoma
7 clinical trials · Condition
◉ Watch High-grade Serous Ovarian Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002) (NCT05446870) | Merck Sharp & Dohme LLC | 2022-07-25 |
| Chromosomal Instability in Ovarian Cancer (NCT05310357) | Lei Li | 2022-03-26 |
| A Study of LY3435151 in Participants With Solid Tumors (NCT04099277) | Eli Lilly and Company | 2019-10-28 |
Track High-grade Serous Ovarian Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.